Correlation Between DiaMedica Therapeutics and EnGene Holdings
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and EnGene Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and EnGene Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and enGene Holdings Common, you can compare the effects of market volatilities on DiaMedica Therapeutics and EnGene Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of EnGene Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and EnGene Holdings.
Diversification Opportunities for DiaMedica Therapeutics and EnGene Holdings
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between DiaMedica and EnGene is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and enGene Holdings Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on enGene Holdings Common and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with EnGene Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of enGene Holdings Common has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and EnGene Holdings go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and EnGene Holdings
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.38 times more return on investment than EnGene Holdings. However, DiaMedica Therapeutics is 2.6 times less risky than EnGene Holdings. It trades about 0.06 of its potential returns per unit of risk. enGene Holdings Common is currently generating about -0.1 per unit of risk. If you would invest 606.00 in DiaMedica Therapeutics on November 28, 2024 and sell it today you would earn a total of 18.00 from holding DiaMedica Therapeutics or generate 2.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. enGene Holdings Common
Performance |
| Timeline |
| DiaMedica Therapeutics |
| enGene Holdings Common |
DiaMedica Therapeutics and EnGene Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and EnGene Holdings
The main advantage of trading using opposite DiaMedica Therapeutics and EnGene Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, EnGene Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnGene Holdings will offset losses from the drop in EnGene Holdings' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| EnGene Holdings vs. GRI Bio | EnGene Holdings vs. Prime Medicine, Common | EnGene Holdings vs. FT Vest Equity | EnGene Holdings vs. Zillow Group Class |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |